Alaunos Therapeutics (TCRT) Q1 2025 Annual Earnings
TCRT·Reported May 15, 2025·Before market open
Alaunos Therapeutics reported Q1 2025 revenue of $2.0K (+100.0% YoY). Diluted EPS came in at $-0.67 (+39.1% YoY), beat the $-6.44 consensus by $5.77.
Revenue
$2.0K
Diluted EPS
$-0.67beat by $5.77
Consensus: $-6.44
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Alaunos Therapeutics's Q1 2025 earnings report.
Alaunos Therapeutics (TCRT) reported Q1 2025 earnings on May 15, 2025 before market open.
Alaunos Therapeutics reported revenue of $2.0K and diluted EPS of $-0.67 for Q1 2025.
EPS beat the consensus estimate of $-6.44 by $5.77.
Compared to the same quarter a year prior, revenue grew 100.0% from $1.0K a year earlier and diluted EPS grew 39.1% from $-1.10.
You can read the 10-K periodic report (0000950170-25-047758) directly on SEC EDGAR. The filing index links above go to sec.gov.